News
IBA, CMI and Life Molecular Imaging announce Japanese approval for the reimbursement of amyloid-PET diagnostic Neuraceq® in Alzheimer's disease
Wednesday, December 13rd, 2023 Louvain-la-Neuve, Belgium, December 13, 2023 – IBA (Ion Beam Applications S.A., EURONEXT), CMI Inc. and Life […]
See moreIBA pioneers theranostic advancements, empowering the market to produce Astatine-211
Tuesday, December 12th, 2023 Rigging of the Cyclone® 30XP in Poland completed with a further two sites in Germany and […]
See more
Successful rigging of IBA's Cyclone Kiube at SIAT, China
Celebrating a significant achievement with the successful rigging of IBA's Cyclone® Kiube at Shenzen Institute of Advanced Technology, Chinese Academy […]
See more
Register for the learn & Talk session at SNMMI
Discover IBA's Learn and Talk sessions at SNMMI: Advantages and Disadvantages of 225Ac-PSMA therapy in Prostate Cancer Patients Prof. Sathkege […]
See more
IBA Launches AKURACY®, an Integrated Solution for Cardiac PET Imaging at EACVI Meeting in Barcelona
The IBA Akuracy® is an innovative user-friendly solution designed for the automated production of 13N-ammonia used for cardiac imaging. Louvain-la-Neuve, […]
See more
Have you already seen a flying Cyclotron?
We are proud to announce that a new Cyclone® KIUBE was rigged in Pretoria, South Africa, at Steve Biko Academic […]
See more
IBA Reports Full Year 2022 Results
ALL-TIME RECORD ORDER INTAKE AND BACKLOG IBA ANNOUNCES MID-TERM GUIDANCE Louvain-la-Neuve, Belgium, 23 March 2023 - IBA (Ion Beam Applications […]
See more
Newsletter 29 is out!
PanTera, IBA Users Meetings, FAPI on Synthera, riggings, site acceptance test,…read it all in our autumn Newsletter ! Read the […]
See more
IBA Business Update – Third Quarter 2022
Louvain-La-Neuve, Belgium, 17 November 2022 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today […]
See more